Celltrion's Truxima leads U.S. prescription market in Feb.
World

Celltrion's Truxima leads U.S. prescription market in Feb.

April 7, 2026
Yonhap News Agency
Scroll

SEOUL, April 7 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceuti...

Celltrion's Truxima leads U.S. prescription market in Feb.
Read Full Article
Yonhap News Agency
Yonhap News Agency

Coverage and analysis from South Korea. All insights are generated by our AI narrative analysis engine.

South Korea
Bias: lean right
You might also like

Explore More